Company Filing History:
Years Active: 1990-1991
Title: Shunsaku Ando: Innovator in Hyposensitization Agents
Introduction
Shunsaku Ando is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of immunology, particularly in the development of hyposensitization agents. With a total of 2 patents, his work focuses on innovative solutions for cedar pollinosis.
Latest Patents
Ando's latest patents include a novel hyposensitization agent that is prepared by covalently attaching a saccharide to a cedar pollen allergen. This agent has a partial amino acid sequence of Ala-Ile-Asn-Ile-Phe-Asn- beginning at its N-terminal. When compared with an intact cedar pollen allergen, this hyposensitization agent significantly accelerates the production of immunoglobulin G and M antibodies specific to the allergen while drastically reducing the production of immunoglobulin E antibodies. This innovation allows for administration to cedar pollinosis patients without the risk of anaphylaxis and allergy, effectively shortening the hyposensitization period to about 1/3 to 1/200.
Another patent focuses on a hyposensitization agent of cedar pollen antigen, which is also prepared by covalently attaching various saccharides to a cedar pollen allergen. This agent enhances the production of immunoglobulin G and M antibodies while minimizing the risk of eliciting anaphylaxis and allergy. The advancements made by Ando in this area are crucial for improving the quality of life for those suffering from cedar pollinosis.
Career Highlights
Shunsaku Ando is associated with Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, where he continues to innovate in the field of immunology. His work has garnered attention for its potential to revolutionize treatment methods for allergies.
Collaborations
Ando collaborates with notable colleagues such as Tyoku Matsuhashi and Mitsuko Usui, contributing to a dynamic research environment that fosters innovation.
Conclusion
Shunsaku Ando's contributions to the development of hyposensitization agents represent a significant advancement in allergy treatment. His innovative approach and dedication to research continue to impact the field positively.